ADVISORY, Feb. 27, 2014 (GLOBE NEWSWIRE)
Amicus Therapeutics, Inc. [FOLD], a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, will visit the NASDAQ MarketSite in Times Square in celebration of Rare Disease Day® 2014. Rare Disease Day is held the last day of February each year and is the occasion to raise awareness for rare diseases. Amicus will be joined by representatives from several patient advocacy organizations including the Global Genes Project, the National Organization for Rare Disorders, the Acid Maltase Deficiency Association, the Fabry Support and Information Group, the National MPS Society, the Histiocytosis Association, the National Fabry Disease Foundation, the National Gaucher Foundation, the National Tay-Sachs & Allied Diseases Association, Jonah Has Just Begun and the United Pompe Foundation.
In honor of the occasion, John Crowley, Chairman and CEO of Amicus will ring the Closing Bell.
Click for more information
Source: Amicus Therapeutics